Jessica Tassan
Stock Analyst at Piper Sandler
(0)
# 4436
Out of 5,218 analysts
82
Total ratings
33.33%
Success rate
-11.28%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Teladoc Health | Reiterates: Overweight | 11 13 | 10.41 | 24.88% | 5 | Dec 4, 2024 | |
Health Catalyst | Reiterates: Overweight | 11 12 | 7.99 | 50.19% | 10 | Nov 26, 2024 | |
CVS Health | Maintains: Overweight | 72 64 | 49.39 | 29.58% | 4 | Nov 25, 2024 | |
Cigna | Reiterates: Overweight | 392 394 | 281.79 | 39.82% | 2 | Nov 5, 2024 | |
Humana | Downgrades: Neutral | 392 274 | 273.6 | 0.15% | 2 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 28 28 | 13.68 | 104.68% | 4 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 40 | 7.22 | 454.02% | 2 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 10 | 11.42 | -12.43% | 4 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 22 | 21.79 | 0.96% | 3 | May 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 566 571 | 521.04 | 9.59% | 4 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 12 15 | 3.49 | 329.8% | 4 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 23 | 52.22 | -55.96% | 3 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 | n/a | n/a | 3 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 43 40 | 24.97 | 60.19% | 4 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 66 70 | 45.99 | 52.21% | 4 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 20 17 | n/a | n/a | 2 | May 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 50 100 | n/a | n/a | 6 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 100 70 | 9.29 | 653.5% | 2 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 39 | n/a | n/a | 2 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 19 | n/a | n/a | 1 | Feb 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 3 | Nov 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 33 | 11.36 | 190.49% | 2 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | n/a | n/a | 1 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 34 31 | n/a | n/a | 2 | Sep 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 16 9 | n/a | n/a | 3 | Jun 23, 2022 |